Standard Biotools Inc.
South San Francisco, CA Doing business as Fluidigm
- UEI
- Q7U7QSDD32W4
- CAGE
- 3HSN3
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Somalogic Operating Co., Inc. · Boulder, CO CTK7E4CB43M7
-
- SAM.gov registration date
- Physical address
- 2 Tower Pl Suite 2000, South San Francisco, CA 94080, USA
- Website
- standardbio.com
- Founded
- 1999
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $205,124 |
| FY2025 | $1,035,154 |
| FY2024 | $293,938 |
| FY2023 | $757,487 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $132,347 | |
| 2 | Department of the Interior | $32,447 | |
| 3 | Department of Commerce | $25,000 | |
| 4 | Department of Health and Human Services | $15,330 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Icahn School Of Medicine At Mount Sinai | N6600119C4022 | $5,726,014 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Diffraction from microvolume topaz microprocessors | National Institutes of Health | $477,466 |
Similar vendors
About the company
Standard Biotools Inc., doing business as Fluidigm, manufactures advanced scientific instruments, reagents, and diagnostic platforms sold to federal research agencies as a prime contractor operating predominantly in full-and-open competition, with no SBA set-aside designations across its recent prime footprint. The South San Francisco-based manufacturer competes across 52 federal customer agencies with a 432-award portfolio spanning over two decades, split heavily toward goods procurement (analytical laboratory instrument manufacturing, diagnostic reagents, consumables) and equipment maintenance services rather than personnel-intensive service contracts.
Fluidigm's capability portfolio centers on mass cytometry systems (Helios, CyTOF), single-cell genomics and genotyping platforms (BioMark, Juno, EP1), real-time PCR instruments (X9), and associated reagent consumables and calibration kits. Representative recent prime work includes a $507 thousand National Institute of Environmental Health Sciences upgrade to a CyTOF XT/Hyperion XTi imaging system with installation, 12-month service plan, and operator training; a $136.8 thousand USDA Agricultural Research Service procurement of a high-throughput nanoliter integrated fluidic circuit genomics system for the Pacific Basin Agricultural Research Center in Hawaii; and a $549.9 thousand Veterans Integrated Service Network 4 maintenance contract through September 2028 covering Hyperion Tissue Imager and Helios CyTOF systems at the Philadelphia VA Medical Center. Equipment maintenance and service agreements dominate the recent award volume, with sole-source justifications grounded in Fluidigm's role as original equipment manufacturer controlling factory-authorized service engineers, proprietary parts, and calibration standards.
Customer concentration skews toward the National Institutes of Health and the Department of Commerce. The National Heart Lung and Blood Institute anchors 74% of the combined potential value across the top five customers with 27 awards totaling $34.4 million. By award count, NOAA leads with 52 awards ($1.5 million combined potential value), followed by USDA Agricultural Research Service (37 awards, $879 thousand), Department of the Interior Fish and Wildlife Service Region 1 (30 awards, $645 thousand), and National Cancer Institute (28 awards, $1.1 million). The divergence between volume and dollar concentration reflects a pattern of many small purchase orders for consumables and routine maintenance alongside fewer, larger-dollar equipment and upgrade contracts anchored at NIH institutes.
Fluidigm operates as a 100% prime contractor across its federal footprint; the source reports 431 prime awards and 1 sub-award, indicating the vendor is not a typical subcontractor to larger systems integrators. The award portfolio skews heavily to NAICS 334516 (Analytical Laboratory Instrument Manufacturing, 291 awards) and PSC codes covering laboratory equipment and supplies (201 awards) and equipment maintenance and repair (89 awards). Recent activity shows a five-year decline: 15 awards in 2022, declining to 2 awards in 2026 year-to-date. The recompete cliff over the next 24 months exposes only $988 thousand across 3 awards completing in that window, indicating limited near-term recompete pressure.
Service Contract Inventory data reveals minimal federal services delivery above the $150 thousand reporting threshold: $365 thousand invoiced across FY2022–FY2025, with $255 thousand in FY2023 and $110 thousand in FY2025. FTE counts reported as 0.0 across all fiscal years in the SCI dataset, indicating that SCI-captured work does not involve billable labor but rather fixed-price goods delivery and equipment maintenance. Median government-paid rates on SCI-reportable service records run $11.4 thousand per hour, with a range from $5.7 thousand to $17.1 thousand per hour — rates consistent with field service engineering and equipment support rather than consulting labor. Fluidigm brings no named subcontractors into SCI-reportable prime contracts. The corporate structure includes Somalogic Operating Co., Inc., a named subsidiary engaged in manufacturing goods, signaling potential portfolio expansion beyond cytometry and genomics instruments into protein analysis and diagnostic reagents.
Quick answers
Is Standard Biotools Inc. registered in SAM.gov?
Yes. Standard Biotools Inc.'s SAM.gov registration is active through March 6, 2027.
How much has Standard Biotools Inc. received in federal contracts?
Federal contracts obligated $1,035,154 to Standard Biotools Inc. in fiscal year 2025 and $2,291,702 in fiscal years 2023 through 2027.
How does Standard Biotools Inc. rank among federal contractors?
Standard Biotools Inc. ranked #13 in NAICS 325414, #19 in PSC 6550 and #59 in NAICS 334516 in FY2025.
What is Standard Biotools Inc.'s most recent federal award?
Standard Biotools Inc.'s most recent federal contract award is LOG106-SC lab's EP1 repair (1305M326P0323), from National Oceanic and Atmospheric Administration, on September 8, 2026.
On GovTribe
See Standard Biotools Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors